Local Treatment for Bone Metastases

Status Not yet recruiting

Clinical Trial Summary

This study will carry out a prospective randomized controlled study to study the effect of different local treatment on disease control, quality of life, economic cost and even survival period of patients by randomly giving local radiotherapy or observation to patients with newly diagnosed bone metastases or patients with bone metastases after vertebroplasty.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05665439
Study type	Interventional
Source	Shanghai 6th People's Hospital
Contact
Status	Not yet recruiting
Phase	N/A
Start date	March 2023
Completion date	March 2026

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03986593` - Cryoablation of Bone Metastases From Endocrine Tumors	N/A
Active, not recruiting	`NCT01996046` - FDG PET/CT in Breast Cancer Bone Mets
Completed	`NCT01358539` - Palliation: the Effect of Education on Pain	Phase 3
Terminated	`NCT00981578` - ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain	N/A
Completed	`NCT00762346` - Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis	Phase 4
Terminated	`NCT00757757` - A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases	Phase 1/Phase 2
Completed	`NCT00420433` - Bone Response in Metastatic Breast Cancer Involving Bones	N/A
Completed	`NCT02826382` - Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041	Early Phase 1
Terminated	`NCT05301062` - A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels
Recruiting	`NCT06367491` - National Database of Bone Metastases
Completed	`NCT03223727` - Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223
Completed	`NCT00830180` - Open Label Extension In Cancer Patients	Phase 2
Active, not recruiting	`NCT03305224` - The Combination Therapy With Ra-223 and Enzalutamide	Phase 2
Withdrawn	`NCT04109937` - External Beam Radiation Therapy Post Surgery in Patients With Lower Extremity Bone Metastases Randomized Efficacy Trial	N/A
Active, not recruiting	`NCT02880943` - Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)	Phase 1/Phase 2
Completed	`NCT01696760` - Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology	N/A
Completed	`NCT00958477` - A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer	Phase 1
Completed	`NCT03979118` - Exercise Prescription in Patients With Bone Metastases
Completed	`NCT03353090` - Double-bed SPECT/CT for Bone Scintigraphy in Initial Staging of Cancer Patients	N/A
Recruiting	`NCT05167669` - Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFU	Early Phase 1